Sun Pharma Q2 FY26 Profit Beats Estimates as India Sales Surge 11%, U.S. Innovative Drugs Outperform

Sun Pharmaceutical Industries, India’s top drugmaker by revenue, reported a quarterly profit above analysts estimates on Wednesday, helped by strong demand for its drugs in the domestic market.The Mumbai-based firm’s consolidated net profit stood at 31.18 billion rupees ($354.7 m

Read More

  • Related Posts

    Is Lotte Choco Pie 100% Vegetarian? FSSAI Says ‘Claim Misleading’, Issues Notice; Ferns N Petals & Kubera Also Under Scanner

    New Delhi: Statutory body Food Safety and Standards Authority of India (FSSAI) has flagged three popular brands, including Kubera Foods, Lotte India Corporation Private Limited and Ferns N Petals Private Limited, over alleged misleading claims and labelling violations on food pro Read More

    Indian Markets Slide As US-Iran Crisis Reignites

    Indian equities have taken a steep hit after the US-Iran crisis flared up again, with President Trump declaring that the ceasefire with Iran was over. As of this writing, the Nifty 50 is trading at 23,882.85, down 515.85 points or 2.11%, while the BSE Sensex has slipped to 25,012 Read More

    Leave a Reply

    Your email address will not be published. Required fields are marked *